BioCentury
ARTICLE | Clinical News

Fabrazyme agalsidase beta regulatory update

January 23, 2012 8:00 AM UTC

Sanofi's Genzyme Corp. unit said EMA approved its Framingham, Mass., manufacturing facility for the production of Fabry's disease therapy Fabrazyme agalsidase beta. Genzyme has experienced supply con...